Shattuck Labs (NASDAQ: STTK)
$0.83
(2.8%)
$0.02
Price as of August 14, 2025, 10:38 a.m. ET
Shattuck Labs Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Shattuck Labs Company Info
Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.